Anagenics Ltd (AN1) - Net Assets

Latest as of June 2026: AU$4.23 Million AUD ≈ $2.99 Million USD

Based on the latest financial reports, Anagenics Ltd (AN1) has net assets worth AU$4.23 Million AUD (≈ $2.99 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$4.75 Million ≈ $3.36 Million USD) and total liabilities (AU$520.80K ≈ $368.50K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check strategic asset allocation of Anagenics Ltd to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$4.23 Million
% of Total Assets	89.03%
Annual Growth Rate	-1.39%
5-Year Change	-49.02%
10-Year Change	-3.84%
Growth Volatility	95.04

Anagenics Ltd - Net Assets Trend (2006–2026)

This chart illustrates how Anagenics Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see AN1 market cap.

Annual Net Assets for Anagenics Ltd (2006–2026)

The table below shows the annual net assets of Anagenics Ltd from 2006 to 2026. Also explore Anagenics Ltd (AN1) equity growth momentum to track the company's year-over-year net asset growth rate.

Year	Net Assets	Change
2026-06-30	AU$4.23 Million ≈ $2.99 Million	+131.38%
2025-06-30	AU$1.83 Million ≈ $1.29 Million	-32.60%
2024-06-30	AU$2.71 Million ≈ $1.92 Million	-69.54%
2023-06-30	AU$8.90 Million ≈ $6.29 Million	+7.31%
2022-06-30	AU$8.29 Million ≈ $5.87 Million	-20.55%
2021-06-30	AU$10.43 Million ≈ $7.38 Million	+6.36%
2020-06-30	AU$9.81 Million ≈ $6.94 Million	+67.50%
2019-06-30	AU$5.86 Million ≈ $4.14 Million	+215.73%
2018-06-30	AU$1.86 Million ≈ $1.31 Million	-57.79%
2017-06-30	AU$4.40 Million ≈ $3.11 Million	-6.29%
2016-06-30	AU$4.69 Million ≈ $3.32 Million	+24.28%
2015-06-30	AU$3.77 Million ≈ $2.67 Million	-33.37%
2014-06-30	AU$5.66 Million ≈ $4.01 Million	+6.76%
2013-06-30	AU$5.31 Million ≈ $3.75 Million	+153.90%
2012-06-30	AU$2.09 Million ≈ $1.48 Million	+2.53%
2011-06-30	AU$2.04 Million ≈ $1.44 Million	-28.47%
2010-06-30	AU$2.85 Million ≈ $2.02 Million	+285.70%
2009-06-30	AU$738.65K ≈ $522.64K	+19.98%
2008-06-30	AU$615.63K ≈ $435.60K	-59.84%
2007-06-30	AU$1.53 Million ≈ $1.08 Million	-72.57%
2006-06-30	AU$5.59 Million ≈ $3.95 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Anagenics Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 6070557300.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2026)

Component	Amount	Percentage
Common Stock	AU$69.28 Million	1639.35%
Other Comprehensive Income	AU$-65.39K	-1.55%
Total Equity	AU$4.23 Million	100.00%

Anagenics Ltd Competitors by Market Cap

The table below lists competitors of Anagenics Ltd ranked by their market capitalization.

Company	Market Cap
Henderson International Income Trust PLC LSE:HINT	$4.18 Million
Recrusul S/A SA:RCSL3	$4.18 Million
Capitan Investment Ltd V:CAI	$4.19 Million
Biophytis S.A. NASDAQ:BPTSY	$4.19 Million
Inhalerx Ltd AU:IRX	$4.18 Million
ASIA Capital Group Public Company Limited BK:ACAP	$4.18 Million
Neola Medical AB ST:NEOLA	$4.18 Million
Sultan Resources Ltd AU:SLZ	$4.17 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Anagenics Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 1,826,488 to 4,226,095, a change of 2,399,607 (131.4%).
Net income of 308,472 contributed positively to equity growth.
Other comprehensive income decreased equity by 8,110.
Other factors increased equity by 2,099,245.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	AU$308.47K	+7.3%
Other Comprehensive Income	AU$-8.11K	-0.19%
Other Changes	AU$2.10 Million	+49.67%
Total Change	AU$-	131.38%

Book Value vs Market Value Analysis

This analysis compares Anagenics Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.05x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has increased from 0.00x to 1.05x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2006-06-30	AU$2.97	AU$0.01	x
2007-06-30	AU$0.51	AU$0.01	x
2008-06-30	AU$0.17	AU$0.01	x
2009-06-30	AU$0.11	AU$0.01	x
2010-06-30	AU$0.19	AU$0.01	x
2011-06-30	AU$0.11	AU$0.01	x
2012-06-30	AU$0.09	AU$0.01	x
2013-06-30	AU$0.17	AU$0.01	x
2014-06-30	AU$0.15	AU$0.01	x
2015-06-30	AU$0.09	AU$0.01	x
2016-06-30	AU$0.10	AU$0.01	x
2017-06-30	AU$0.08	AU$0.01	x
2018-06-30	AU$0.03	AU$0.01	x
2019-06-30	AU$0.07	AU$0.01	x
2020-06-30	AU$0.09	AU$0.01	x
2021-06-30	AU$0.07	AU$0.01	x
2022-06-30	AU$0.04	AU$0.01	x
2023-06-30	AU$0.03	AU$0.01	x
2024-06-30	AU$0.01	AU$0.01	x
2025-06-30	AU$0.00	AU$0.01	x
2026-06-30	AU$0.01	AU$0.01	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Anagenics Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 7.30%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 5.98%
• Asset Turnover: 1.09x
• Equity Multiplier: 1.12x
Recent ROE (7.30%) is above the historical average (-123.92%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2006	-50.06%	0.00%	0.00x	1.11x	AU$-3.31 Million
2007	-297.12%	0.00%	0.00x	3.08x	AU$-4.71 Million
2008	-436.76%	0.00%	0.00x	4.23x	AU$-2.75 Million
2009	-451.44%	0.00%	0.00x	1.65x	AU$-3.41 Million
2010	-47.03%	0.00%	0.00x	1.13x	AU$-1.62 Million
2011	-111.37%	-7224.00%	0.01x	1.38x	AU$-2.47 Million
2012	-93.63%	-1395.45%	0.06x	1.20x	AU$-2.18 Million
2013	-28.65%	-281.90%	0.09x	1.12x	AU$-2.06 Million
2014	-26.02%	-67.09%	0.34x	1.14x	AU$-2.04 Million
2015	-88.43%	-181.10%	0.30x	1.63x	AU$-3.71 Million
2016	-74.60%	-112.13%	0.42x	1.58x	AU$-3.97 Million
2017	-101.71%	-99.42%	0.53x	1.93x	AU$-4.91 Million
2018	-201.20%	-66.09%	0.84x	3.64x	AU$-3.92 Million
2019	-100.89%	-80.93%	0.75x	1.67x	AU$-6.50 Million
2020	-50.02%	-66.49%	0.50x	1.52x	AU$-5.89 Million
2021	-32.46%	-58.23%	0.44x	1.27x	AU$-4.43 Million
2022	-44.02%	-52.54%	0.54x	1.56x	AU$-4.48 Million
2023	-29.98%	-29.27%	0.82x	1.25x	AU$-3.56 Million
2024	-276.52%	-69.36%	1.74x	2.29x	AU$-7.76 Million
2025	-67.65%	-26.04%	1.16x	2.25x	AU$-1.42 Million
2026	7.30%	5.98%	1.09x	1.12x	AU$-114.14K

Industry Comparison

This section compares Anagenics Ltd's net assets metrics with peer companies in the Household & Personal Products industry.

Industry Context

Industry: Household & Personal Products
Average net assets among peers: $41,462,974
Average return on equity (ROE) among peers: -4.70%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Anagenics Ltd (AN1)	AU$4.23 Million	-50.06%	0.12x	$4.18 Million
Mcphersons Ltd (MCP)	$141.09 Million	0.66%	1.64x	$12.73 Million
Prestal Holdings Ltd (PTL)	$49.57 Million	0.26%	1.88x	$2.77 Million
Star Combo Pharma Ltd (S66)	$15.68 Million	10.43%	0.23x	$13.38 Million
Skin Elements Ltd (SKN)	$-1.94 Million	0.00%	0.00x	$6.52 Million
ZOONO Group Ltd (ZNO)	$2.91 Million	-34.84%	0.02x	$16.10 Million

About Anagenics Ltd

AU:AN1 Australia Household & Personal Products

Market Cap

$4.18 Million

AU$5.91 Million AUD

Market Cap Rank

#29015 Global

#1587 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.00 - AU$0.01

All Time High

AU$0.70